Guinea bauxite can make up for Indonesia ban, China’s Antaike says

FAN Editor
FILE PHOTO: A excavator dumps bauxite ore into a dump truck at a mine belonging to China's Bosai Minerals Group in Linden
FILE PHOTO: A excavator dumps bauxite ore into a dump truck at a mine belonging to China’s Bosai Minerals Group in Linden, April 24, 2011. REUTERS/Andrea De Silva

November 26, 2021

(Reuters) – A possible ban on exports of bauxite from Indonesia as soon as next year will have little impact on China’s aluminium industry because abundant alternative supply from Guinea is available, state-backed Chinese research house Antaike said.

Indonesian President Joko Widodo on Wednesday said the Southeast Asian country could stop allowing exports of bauxite, the main aluminium ore, from 2022 as it looks to process more of its resources at home.

Jakarta previous banned bauxite exports in 2014, before which Indonesia was China’s biggest supplier, only to allow them to resume in 2017.

“If Indonesia again restricts bauxite exports, Guinea’s bauxite capacity surplus can completely make up for Indonesia’s shortfall,” Antaike wrote in a note late on Thursday.

Chinese-invested bauxite mining projects in the West African country have annual production capacity of over 100 million tonnes, it noted, adding that almost all the material was shipped to China, where it is refined into alumina, the substance used to make aluminium metal.

China, the world’s top aluminium maker, imported more than 91 million tonnes of bauxite in January-October. Indonesia was its third-biggest supplier with a share of 15%, behind Guinea and Australia.

Imports from Guinea are expected to reach 58 million tonnes this year and there is still a lot of room for that to increase further, Antaike noted.

(Reporting by Tom Daly; Editing by Sandra Maler)

Free America Network Articles

Leave a Reply

Next Post

This week on "Sunday Morning" (November 28)

Host: Jane Pauley COVER STORY: Hopes and fears over a new Alzheimer’s drugThe FDA’s recent approval of a new drug, Aduhelm, to clear the formation of amyloid plaques in the brain is potentially good news for the six million Americans who suffer from Alzheimer’s disease. But the approval process for […]

You May Like